false
OasisLMS
Catalog
AOHC Encore 2022
124: COVID-19 Isn't the Only Virus, What's Next on ...
124: COVID-19 Isn't the Only Virus, What's Next on the Pandemic List
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video features a panel discussion on various topics related to COVID-19. The panelists include Dr. Robert Quigley, Dr. Myles Druckmann, and Dr. Brad Hirsch. They discuss lessons learned from the pandemic, including virus mutation, transmissibility, comorbidities' impact, immune response, vaccine effectiveness, breakthrough infections, and long-haul effects. The challenges faced by corporate medical directors in implementing health and safety measures are also discussed, along with the balancing between public health and the economy. The panelists touch on therapeutics, changing recommendations, and credibility. Repurposed drugs and evidence-based medicine are also addressed. No credits are provided.<br /><br />In this video, a discussion takes place between Dr. Brad Hirsch, Dr. Rob Druckman, and an unnamed moderator. They cover various COVID-19 related topics, including vaccine hesitancy, social media, virus mutation, herd immunity, dynamic pandemic planning, global warming's impact, and bioterrorism. Dr. Druckman emphasizes medical directors' role in pandemic preparedness and disease surveillance. The immune response to COVID-19 and natural vs. vaccine-induced immunity are discussed. The challenges faced by organizations like the CDC and WHO in disseminating accurate information and responding to the pandemic's evolving nature are acknowledged. Overall, the video provides insights into the current state of the pandemic and the ongoing need for effective public health measures and planning.
Keywords
COVID-19
panel discussion
lessons learned
virus mutation
transmissibility
comorbidities' impact
immune response
vaccine effectiveness
breakthrough infections
long-haul effects
public health
economy
×
Please select your language
1
English